Impact of CYP1A1 variants on the risk of acute lymphoblastic leukemia: evidence from an updated meta-analysis
- PMID: 38485870
- PMCID: PMC10917727
- DOI: 10.1007/s44313-024-00007-9
Impact of CYP1A1 variants on the risk of acute lymphoblastic leukemia: evidence from an updated meta-analysis
Abstract
Objective: Our study aimed to investigate the association between cytochrome P450 1A1 (CYP1A1) polymorphisms (T3801C and A2455G) and acute lymphoblastic leukemia (ALL) risk, considering genetic models and ethnicity.
Materials and methods: PubMed, Embase, Web of Knowledge, Scopus, and the Cochrane electronic databases were searched using combinations of keywords related to CYP1A1 polymorphisms and the risk of ALL. Studies retrieved from the database searches underwent screening based on strict inclusion and exclusion criteria.
Results: In total, 2822 cases and 4252 controls, as well as 1636 cases and 2674 controls of the C3801T and A2455G variants of CYP1A1, respectively, were included in this meta-analysis. The T3801C polymorphism of CYP1A1 significantly increases the risk of ALL, particularly those observed in Asian and Hispanic populations, independent of age. Similarly, the A2455G polymorphism of CYP1A1 plays a significant role in the susceptibility to ALL in all genetic models, except the heterozygous form. This association was observed mainly in mixed populations and in both children and adults (except in the heterozygous model).
Conclusion: Our comprehensive analysis indicates that the T3801 and A2455G polymorphisms of CYP1A1 may increase the risk of ALL depending on ethnicity. Therefore, both variants should be considered promising biomarkers for ALL risk. Further large-scale investigations are necessary to assess other factors, such as gene-gene or gene-environment interactions.
Keywords: Acute lymphoblastic leukemia; Cytochrome; Meta-analysis; Risk.
© 2024. The Author(s).
Conflict of interest statement
None.
Figures
Similar articles
-
Evaluation of association studies and a systematic review and meta-analysis of CYP1A1 T3801C and A2455G polymorphisms in breast cancer risk.PLoS One. 2021 Apr 28;16(4):e0249632. doi: 10.1371/journal.pone.0249632. eCollection 2021. PLoS One. 2021. PMID: 33909612 Free PMC article.
-
Association between CYP1A1 polymorphisms and esophageal cancer: a meta-analysis.Mol Biol Rep. 2013 Oct;40(10):6035-42. doi: 10.1007/s11033-013-2713-1. Epub 2013 Sep 25. Mol Biol Rep. 2013. PMID: 24065535
-
Cytochrome P450 1A1 (CYP1A1) T3801C and A2455G polymorphisms in breast cancer risk: a meta-analysis.J Hum Genet. 2007;52(5):423. doi: 10.1007/s10038-007-0131-8. Epub 2007 Apr 11. J Hum Genet. 2007. PMID: 17427032
-
Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis.Breast Cancer Res Treat. 2010 Jul;122(2):459-69. doi: 10.1007/s10549-009-0694-5. Epub 2009 Dec 25. Breast Cancer Res Treat. 2010. PMID: 20035380 Review.
-
Genetic polymorphisms of CYP1A1 and risk of leukemia: a meta-analysis.Onco Targets Ther. 2015 Oct 12;8:2883-902. doi: 10.2147/OTT.S92259. eCollection 2015. Onco Targets Ther. 2015. PMID: 26491362 Free PMC article.
References
-
- Samuel W, Lovell J, Christine C, Kathi H, editors. Cancer and the Environment: Gene-Environment Interactions. Washington, D.C.: National Academies Press; 2002. 10.17226/10464.
LinkOut - more resources
Full Text Sources